2026年生物製藥冷藏物流鏈全球市場報告

近年來，生物製藥低溫運輸物流市場發展迅速。預計該市場規模將從2025年的164.7億美元成長到2026年的180億美元，複合年成長率（CAGR）為9.3%。過去幾年成長要素包括生物製藥產量增加、疫苗分銷要求更加嚴格、臨床試驗物流規模擴大、冷藏運輸網路不斷完善以及被動式保溫包裝的普及應用。

預計未來幾年生物製藥低溫運輸物流市場將維持強勁成長，到2030年市場規模將達到258.7億美元，複合年成長率（CAGR）為9.5%。預測期內的成長要素包括：主動溫控容器的廣泛應用、對低溫運輸監控服務需求的成長、可重複使用保溫包裝材料的廣泛應用、短期運輸儲存解決方案的擴展，以及與人工智慧和物聯網物流系統的日益融合。預測期間的關鍵趨勢包括：溫控包裝解決方案的廣泛應用、對末端低溫運輸配送需求的成長、即時低溫運輸監控的進一步整合、冷藏和低溫儲存設施的擴張，以及對合規和監管服務的日益重視。

預計未來幾年，對個人化醫療日益成長的需求將推動生物製藥低溫運輸物流市場的擴張。個人化醫療是一種根據每位患者獨特的生物學和個人特徵量身定做治療方法的醫療方法。基因組學的進步正在推動個人化醫療的普及，因為醫療服務提供者能夠快速且準確地分析患者的基因訊息，從而實現更精準有效的治療。生物製藥低溫運輸物流在支持個人化醫療方面發揮著至關重要的作用，它確保個人化治療方法在指定的溫度和處理條件下保存，並在送達患者手中之前保持其安全性和有效性。例如，總部位於美國的非營利組織個人化醫療聯盟（Personalized Medicine Coalition）於2024年2月報告稱，美國食品藥物管理局（FDA）在2023年核准了16種用於治療罕見疾病的新型個人化治療方法，高於2022年的6核准。 2023年新核准的個人化治療方法包括7種抗癌藥物和3種用於治療其他疾病和病症的治療方法。因此，對個人化醫療日益成長的需求正在推動生物製藥低溫運輸物流市場的成長。

生物製藥低溫運輸物流市場的領導者正致力於開發創新解決方案，例如可重複使用的溫控托盤運輸箱，以確保對溫度敏感的生物製藥的安全、永續且經濟高效地運輸。可重複使用的溫控托盤運輸箱是一種耐用且用途廣泛的容器，能夠維持穩定的溫度，從而安全地運輸對溫度敏感的生物製藥產品。例如，總部位於美國的包裝公司 Cold Chain Technologies LLC 於 2025 年 4 月推出了 CCT Tower Elite，這是一款容量為 1600 公升的可重複使用溫控托盤運輸箱，專為生命科學物流而設計。該產品整合了物聯網 (IoT) 功能，可進行即時監控。它採用相變材料 (PCM)，可在 -60 度C至 +5 度C和 +20 度C的溫度範圍內保持 120 小時以上的穩定性，並相容於運輸疫苗、生物製藥和基因療法產品，例如 RoSS® 外殼和 API 桶裝產品。其輕巧、可空運的結構和全球再利用網路促進了藥品運輸的永續性。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球生物製藥冷藏物流鏈市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 人工智慧和自主智慧
  • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 工業4.0和智慧製造
• 主要趨勢
  • 溫控包裝解決方案的廣泛應用
  • 對最後一公里低溫運輸配送的需求日益成長
  • 即時低溫運輸監控的整合工作正在推進中。
  • 冷藏和低溫倉儲設施的擴建
  • 人們對合規和監管服務越來越感興趣。

第5章 終端用戶產業市場分析

• 製藥和生物技術公司
• 醫療服務提供方
• 研究機構
• 受託研究機構
• 臨床試驗的贊助商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球生物製藥冷藏物流鏈市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球生物製藥冷藏物流鏈市場：規模、對比及成長率分析
• 全球生物製藥冷藏物流鏈市場表現：規模與成長，2020-2025年
• 全球生物製藥冷藏物流市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按服務類型
• 運輸、倉儲、包裝及其他服務類型
• 依產品類型
• 疫苗、臨床試驗樣本、生物製藥及其他產品類型
• 按溫度範圍
• 冷凍、冷凍、低溫及其他溫度範圍
• 交通途徑
• 航空、公路、海運、鐵路
• 最終用戶
• 製藥和生物技術公司、醫療保健提供者、研究機構和其他最終用戶
• 細分：依類型：運輸
• 冷藏陸運、溫控空運、保溫海運、最後一公里冷藏配送。
• 細分：按類型：存儲
• 冷藏倉庫、冷凍倉儲設施、低溫儲存、短期中轉存儲
• 細分：依類型：包裝
• 被動式保溫包裝、主動式溫控容器、可重複使用的保溫包裝、拋棄式低溫運輸包裝
• 細分：按類型：其他服務類型
• 低溫運輸監控服務、驗證與合格服務、庫存管理服務、法規遵循支援服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 生物製藥冷藏物流鏈市場：競爭格局及市場佔有率（2024年）
• 生技製藥冷藏物流鏈市場：公司估價矩陣
• 生物製藥冷藏物流鏈市場：公司概況
  • Cencora Inc.
  • DHL Group
  • United Parcel Service of America Inc.
  • FedEx Corporation
  • AP Moller-Maersk A/S

第37章 其他大型企業和創新企業

• SF Holding Co. Ltd., Schenker AG, CEVA Logistics SA, Nippon Express Holdings Inc., GXO Logistics Inc., Sonoco Products Company, Agility Public Warehousing Company KSCP, Americold Realty Trust Inc., Marken Ltd., Pelican Products Inc., Cold Chain Technologies LLC, Controlant hf., Sensitech Inc., Envirotainer AB, QuickSTAT Global Life Science Logistics LLC

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年生物製藥冷藏物流鏈市場：提供新機會的國家
• 2030年生物製藥冷藏鏈物流市場：充滿新機會的細分市場
• 2030年生物製藥冷藏鏈物流市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Biopharmaceutical cold chain logistics involves the transport and storage of biopharmaceutical products under tightly controlled temperature conditions to maintain their safety, stability, and effectiveness. It ensures that temperature-sensitive products retain their efficacy throughout the journey from production to end-user delivery.

The key service types of biopharmaceutical cold chain logistics include transportation, storage, packaging, and other service types. Transportation involves the organized movement of temperature-sensitive biopharmaceutical products from manufacturing sites to storage or administration locations. The logistics cover product types such as vaccines, clinical trial materials, biopharmaceuticals, and others, with temperature ranges including refrigerated, frozen, cryogenic, and other conditions. Modes of transport include airways, roadways, seaways, and railways, serving end users such as pharmaceutical and biotechnology companies, healthcare providers, research institutes, and others.

Tariffs on imported refrigeration equipment, insulated packaging materials, and monitoring devices are impacting the biopharmaceutical cold chain logistics market by increasing operational and capital costs, particularly affecting transportation, storage, and packaging service segments. Regions such as North America, Europe, and Asia-Pacific, which depend on imported cold chain infrastructure, are most affected. While tariffs raise costs, they also encourage domestic manufacturing of temperature-controlled solutions, enhance local supply chain resilience, and drive innovation in energy-efficient and cost-optimized cold chain technologies.

The biopharmaceutical cold chain logistics market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical cold chain logistics market statistics, including biopharmaceutical cold chain logistics industry global market size, regional shares, competitors with a biopharmaceutical cold chain logistics market share, detailed biopharmaceutical cold chain logistics market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical cold chain logistics industry. This biopharmaceutical cold chain logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical cold chain logistics market size has grown strongly in recent years. It will grow from $16.47 billion in 2025 to $18 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising biopharmaceutical production volumes, increasing vaccine distribution requirements, growth of clinical trial logistics, expansion of refrigerated transport networks, adoption of passive insulated packaging.

The biopharmaceutical cold chain logistics market size is expected to see strong growth in the next few years. It will grow to $25.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing adoption of active temperature-controlled containers, increasing demand for cold chain monitoring services, rising deployment of reusable thermal packaging, expansion of short-term transit storage solutions, increasing integration with AI and IoT-enabled logistics systems. Major trends in the forecast period include increasing adoption of temperature-controlled packaging solutions, rising demand for last-mile cold chain delivery, growing integration of real-time cold chain monitoring, expansion of refrigerated and cryogenic storage facilities, rising focus on compliance and regulatory support services.

The increasing demand for personalized medicine is anticipated to drive the expansion of the biopharmaceutical cold chain logistics market in the coming years. Personalized medicine is a healthcare approach that tailors treatments based on an individual patient's unique biological and personal attributes. Its adoption is rising due to advancements in genomic technologies, which enable healthcare providers to quickly and accurately analyze a patient's genetic information, facilitating more precise and effective therapies. Biopharmaceutical cold chain logistics play a crucial role in supporting personalized medicine by ensuring that individualized therapies are maintained under the required temperature and handling conditions, preserving their safety and efficacy until they reach patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Among the newly approved personalized treatments for 2023 were seven cancer drugs and three therapies for other diseases and conditions. Consequently, the rising demand for personalized medicine is fueling the growth of the biopharmaceutical cold chain logistics market.

Leading companies operating in the biopharmaceutical cold chain logistics market are focusing on developing innovative solutions such as reusable temperature-controlled pallet shippers to ensure safe, sustainable, and cost-efficient transport of temperature-sensitive biologics. A reusable temperature-controlled pallet shipper is a durable, multi-use container that maintains stable temperatures for safely transporting temperature-sensitive biopharmaceuticals. For example, in April 2025, Cold Chain Technologies LLC, a US-based packaging company, launched a reusable CCT Tower Elite, a 1600 L temperature-controlled pallet shipper designed for life sciences logistics, featuring integrated IoT for real-time monitoring. It is engineered to maintain stability over 120 hours at temperatures like <-60°C, +5°C, and +20°C using phase-change materials, supporting vaccines, biologics, and gene therapies in formats such as RoSS(R) shells and API drums. Its lightweight, aircraft-compatible construction and global reuse network promote sustainability in pharma shipments.

In November 2025, UPS Healthcare Inc., a healthcare logistics and supply chain company based in the US, acquired Andlauer Healthcare Group Inc. for an undisclosed sum. Through this acquisition, UPS Healthcare seeks to enhance its cold chain logistics capabilities by utilizing Andlauer Healthcare Group's specialized temperature-controlled transportation and storage solutions, ensuring more reliable delivery of temperature-sensitive pharmaceuticals and vaccines. Andlauer Healthcare Group Inc., headquartered in Canada, is a healthcare logistics company focused on cold chain distribution and supply chain management for the healthcare sector.

Major companies operating in the biopharmaceutical cold chain logistics market are Cencora Inc., DHL Group, United Parcel Service of America Inc., FedEx Corporation, A.P. Moller - Maersk A/S, SF Holding Co. Ltd., Schenker AG, CEVA Logistics S.A., Nippon Express Holdings Inc., GXO Logistics Inc., Sonoco Products Company, Agility Public Warehousing Company K.S.C.P., Americold Realty Trust Inc., Marken Ltd., Pelican Products Inc., Cold Chain Technologies LLC, Controlant hf., Sensitech Inc., Envirotainer AB, QuickSTAT Global Life Science Logistics LLC, Cryopak Industries Inc., DGP Intelsius Ltd., Tower Cold Chain Solutions Ltd., and Snowman Logistics Limited.

North America was the largest region in the biopharmaceutical cold chain logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cold chain logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical cold chain logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical cold chain logistics market consists of revenues earned by entities by providing services such as temperature-controlled transportation, cold storage and warehousing, packaging and conditioning, real-time temperature monitoring, regulatory compliance support, and last-mile distribution of biopharmaceutical products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Cold Chain Logistics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biopharmaceutical cold chain logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical cold chain logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical cold chain logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service Type: Transportation; Storage; Packaging; Other Service Types
• 2) By Product Type: Vaccines; Clinical Trial Materials; Biopharmaceuticals; Other Product Types
• 3) By Temperature Range: Refrigerated; Frozen; Cryogenic; Other Temperature Ranges
• 4) By Mode Of Transportation: Airways; Roadways; Seaways; Railways
• 5) By End-User: Pharmaceutical And Biotechnology Companies; Healthcare Providers; Research Institutes; Other End Users
• Subsegments:
• 1) By Transportation: Refrigerated Road Transport; Temperature Controlled Air Freight; Insulated Sea Freight; Last Mile Cold Delivery
• 2) By Storage: Refrigerated Warehousing; Frozen Storage Facilities; Cryogenic Storage; Short Term Transit Storage
• 3) By Packaging: Passive Insulated Packaging; Active Temperature Controlled Containers; Reusable Thermal Packaging; Single Use Cold Chain Packaging
• 4) By Other Service Types: Cold Chain Monitoring Services; Validation And Qualification Services; Inventory Management Services; Regulatory Compliance Support Services
• Companies Mentioned: Cencora Inc.; DHL Group; United Parcel Service of America Inc.; FedEx Corporation; A.P. Moller - Maersk A/S; SF Holding Co. Ltd.; Schenker AG; CEVA Logistics S.A.; Nippon Express Holdings Inc.; GXO Logistics Inc.; Sonoco Products Company; Agility Public Warehousing Company K.S.C.P.; Americold Realty Trust Inc.; Marken Ltd.; Pelican Products Inc.; Cold Chain Technologies LLC; Controlant hf.; Sensitech Inc.; Envirotainer AB; QuickSTAT Global Life Science Logistics LLC; Cryopak Industries Inc.; DGP Intelsius Ltd.; Tower Cold Chain Solutions Ltd.; and Snowman Logistics Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biopharmaceutical Cold Chain Logistics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biopharmaceutical Cold Chain Logistics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biopharmaceutical Cold Chain Logistics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biopharmaceutical Cold Chain Logistics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption of Temperature-Controlled Packaging Solutions
  • 4.2.2 Rising Demand for Last-Mile Cold Chain Delivery
  • 4.2.3 Growing Integration of Real-Time Cold Chain Monitoring
  • 4.2.4 Expansion of Refrigerated and Cryogenic Storage Facilities
  • 4.2.5 Rising Focus on Compliance and Regulatory Support Services

5. Biopharmaceutical Cold Chain Logistics Market Analysis Of End Use Industries

• 5.1 Pharmaceutical And Biotechnology Companies
• 5.2 Healthcare Providers
• 5.3 Research Institutes
• 5.4 Contract Research Organizations
• 5.5 Clinical Trial Sponsors

6. Biopharmaceutical Cold Chain Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biopharmaceutical Cold Chain Logistics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biopharmaceutical Cold Chain Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biopharmaceutical Cold Chain Logistics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biopharmaceutical Cold Chain Logistics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biopharmaceutical Cold Chain Logistics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biopharmaceutical Cold Chain Logistics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biopharmaceutical Cold Chain Logistics Market Segmentation

• 9.1. Global Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transportation, Storage, Packaging, Other Service Types
• 9.2. Global Biopharmaceutical Cold Chain Logistics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vaccines, Clinical Trial Materials, Biopharmaceuticals, Other Product Types
• 9.3. Global Biopharmaceutical Cold Chain Logistics Market, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Refrigerated, Frozen, Cryogenic, Other Temperature Ranges
• 9.4. Global Biopharmaceutical Cold Chain Logistics Market, Segmentation By Mode Of Transportation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Airways, Roadways, Seaways, Railways
• 9.5. Global Biopharmaceutical Cold Chain Logistics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotechnology Companies, Healthcare Providers, Research Institutes, Other End Users
• 9.6. Global Biopharmaceutical Cold Chain Logistics Market, Sub-Segmentation Of Transportation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Refrigerated Road Transport, Temperature Controlled Air Freight, Insulated Sea Freight, Last Mile Cold Delivery
• 9.7. Global Biopharmaceutical Cold Chain Logistics Market, Sub-Segmentation Of Storage, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Refrigerated Warehousing, Frozen Storage Facilities, Cryogenic Storage, Short Term Transit Storage
• 9.8. Global Biopharmaceutical Cold Chain Logistics Market, Sub-Segmentation Of Packaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Passive Insulated Packaging, Active Temperature Controlled Containers, Reusable Thermal Packaging, Single Use Cold Chain Packaging
• 9.9. Global Biopharmaceutical Cold Chain Logistics Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cold Chain Monitoring Services, Validation And Qualification Services, Inventory Management Services, Regulatory Compliance Support Services

10. Biopharmaceutical Cold Chain Logistics Market Regional And Country Analysis

• 10.1. Global Biopharmaceutical Cold Chain Logistics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biopharmaceutical Cold Chain Logistics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biopharmaceutical Cold Chain Logistics Market

• 11.1. Asia-Pacific Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biopharmaceutical Cold Chain Logistics Market

• 12.1. China Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biopharmaceutical Cold Chain Logistics Market

• 13.1. India Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biopharmaceutical Cold Chain Logistics Market

• 14.1. Japan Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biopharmaceutical Cold Chain Logistics Market

• 15.1. Australia Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biopharmaceutical Cold Chain Logistics Market

• 16.1. Indonesia Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biopharmaceutical Cold Chain Logistics Market

• 17.1. South Korea Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biopharmaceutical Cold Chain Logistics Market

• 18.1. Taiwan Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biopharmaceutical Cold Chain Logistics Market

• 19.1. South East Asia Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biopharmaceutical Cold Chain Logistics Market

• 20.1. Western Europe Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biopharmaceutical Cold Chain Logistics Market

• 21.1. UK Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biopharmaceutical Cold Chain Logistics Market

• 22.1. Germany Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biopharmaceutical Cold Chain Logistics Market

• 23.1. France Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biopharmaceutical Cold Chain Logistics Market

• 24.1. Italy Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biopharmaceutical Cold Chain Logistics Market

• 25.1. Spain Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biopharmaceutical Cold Chain Logistics Market

• 26.1. Eastern Europe Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biopharmaceutical Cold Chain Logistics Market

• 27.1. Russia Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biopharmaceutical Cold Chain Logistics Market

• 28.1. North America Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biopharmaceutical Cold Chain Logistics Market

• 29.1. USA Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biopharmaceutical Cold Chain Logistics Market

• 30.1. Canada Biopharmaceutical Cold Chain Logistics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biopharmaceutical Cold Chain Logistics Market

• 31.1. South America Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biopharmaceutical Cold Chain Logistics Market

• 32.1. Brazil Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biopharmaceutical Cold Chain Logistics Market

• 33.1. Middle East Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biopharmaceutical Cold Chain Logistics Market

• 34.1. Africa Biopharmaceutical Cold Chain Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biopharmaceutical Cold Chain Logistics Market, Segmentation By Service Type, Segmentation By Product Type, Segmentation By Temperature Range, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biopharmaceutical Cold Chain Logistics Market Regulatory and Investment Landscape

36. Biopharmaceutical Cold Chain Logistics Market Competitive Landscape And Company Profiles

• 36.1. Biopharmaceutical Cold Chain Logistics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biopharmaceutical Cold Chain Logistics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biopharmaceutical Cold Chain Logistics Market Company Profiles
  • 36.3.1. Cencora Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. DHL Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. United Parcel Service of America Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. FedEx Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. A.P. Moller - Maersk A/S Overview, Products and Services, Strategy and Financial Analysis

37. Biopharmaceutical Cold Chain Logistics Market Other Major And Innovative Companies

• SF Holding Co. Ltd., Schenker AG, CEVA Logistics S.A., Nippon Express Holdings Inc., GXO Logistics Inc., Sonoco Products Company, Agility Public Warehousing Company K.S.C.P., Americold Realty Trust Inc., Marken Ltd., Pelican Products Inc., Cold Chain Technologies LLC, Controlant hf., Sensitech Inc., Envirotainer AB, QuickSTAT Global Life Science Logistics LLC

38. Global Biopharmaceutical Cold Chain Logistics Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Biopharmaceutical Cold Chain Logistics Market

41. Biopharmaceutical Cold Chain Logistics Market High Potential Countries, Segments and Strategies

• 41.1 Biopharmaceutical Cold Chain Logistics Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Biopharmaceutical Cold Chain Logistics Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Biopharmaceutical Cold Chain Logistics Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer